Dysregulation of cell metabolism occurs under multiple pathological conditions.
We are exploring aggressive biomaterial-based interventions designed to treat the primary pathological components of AMD.
BRD4, a bromodomain and extraterminal domain (BET) family member, is an attractive target in multiple pathological settings, particularly cancer.
Our study suggests that TGFβ contributes to multiple pathological processes responsible for oral mucositis development.
Oral mucositis has multiple pathological processes, hence targeting one of them is insufficient for therapeutic efficacy.
Multiple pathological pathways contribute to the final phenotype of PE.
It was confirmed that CT and/or MRI findings of ICC were correlated with pathological components.
Necessarily, the pathological components of our study are cross-sectional, not longitudinal.
In summary, it is postulated that multiple pathological reactions occur during ANFH.
They are also implicated in multiple pathological states, such as cancer, neurodegeneration and aging.
